Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Barquín M, Calvo V, García-García F, Nuñez B, Sánchez-Herrero E, Serna-Blasco R, Auglytė M, Carcereny E, Rodriguez-Abreu D, López Castro R, Guirado M, Camps C, Bosch-Barrera J, Massuti B, Ortega AL, Del Barco E, Gonzalez-Larriba JL, Aguiar D, García-Campelo R, Dómine M, Agraso S, Sala MA, Oramas J, Bernabé R, Blanco R, Parejo C, Cruz A, Menasalvas E, Royuela A, Romero A, Provencio M. Barquín M, et al. Among authors: calvo v. Cancer Epidemiol. 2020 Aug;67:101737. doi: 10.1016/j.canep.2020.101737. Epub 2020 May 22. Cancer Epidemiol. 2020. PMID: 32450544
Survival in young adults diagnosed with follicular lymphoma.
Calvo V, Provencio M, Gómez Codina J, Rodríguez Abreu D, Rueda A. Calvo V, et al. Ann Oncol. 2016 Apr;27(4):751. doi: 10.1093/annonc/mdv627. Epub 2015 Dec 28. Ann Oncol. 2016. PMID: 26715622 Free article. No abstract available.
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
Pérez-Barrios C, Nieto-Alcolado I, Torrente M, Jiménez-Sánchez C, Calvo V, Gutierrez-Sanz L, Palka M, Donoso-Navarro E, Provencio M, Romero A. Pérez-Barrios C, et al. Among authors: calvo v. Transl Lung Cancer Res. 2016 Dec;5(6):665-672. doi: 10.21037/tlcr.2016.12.03. Transl Lung Cancer Res. 2016. PMID: 28149760 Free PMC article.
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
Provencio M, Sabín P, Gomez-Codina J, Torrente M, Calvo V, Llanos M, Gumá J, Quero C, Blasco A, Cruz MA, Aguiar D, García-Arroyo F, Lavernia J, Martinez N, Morales M, Saez-Cusi A, Rodriguez D, de la Cruz L, Sanchez JJ, Rueda A; GOTEL (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: calvo v. PLoS One. 2017 May 11;12(5):e0177204. doi: 10.1371/journal.pone.0177204. eCollection 2017. PLoS One. 2017. PMID: 28493986 Free PMC article.
Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
Provencio M, Royuela A, Torrente M, Pollán M, Gómez-Codina J, Sabín P, Llanos M, Gumá J, Quero C, Blasco A, Aguiar D, García-Arroyo FR, Lavernia J, Martínez N, Morales M, Saenz-Cusi Á, Rodríguez D, Calvo V, de la Cruz-Merino L, de la Cruz MÁ, Rueda A; Spanish Lymphoma Oncology Group. Provencio M, et al. Among authors: calvo v. Cancer. 2017 Oct 1;123(19):3709-3716. doi: 10.1002/cncr.30795. Epub 2017 Jun 13. Cancer. 2017. PMID: 28608996 Free article.
Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.
Provencio M, Pérez-Callejo D, Torrente M, Martin P, Calvo V, Gutiérrez L, Franco F, Coronado MJ, Cruz-Bermúdez JL, Ruiz-Valdepeñas AM, Cruz-Bermúdez A, Sánchez-Beato M, Romero A, García-Grande A. Provencio M, et al. Among authors: calvo v. Oncotarget. 2017 Jul 31;8(35):59408-59416. doi: 10.18632/oncotarget.19722. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938646 Free PMC article.
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.
Cruz-Bermúdez A, Vicente-Blanco RJ, Laza-Briviesca R, García-Grande A, Laine-Menéndez S, Gutiérrez L, Calvo V, Romero A, Martín-Acosta P, García JM, Provencio M. Cruz-Bermúdez A, et al. Among authors: calvo v. Sci Rep. 2017 Nov 30;7(1):16661. doi: 10.1038/s41598-017-17009-6. Sci Rep. 2017. PMID: 29192176 Free PMC article.
253 results